Skip to main content
. 2016 Mar;22(3):e151430. doi: 10.3201/eid2203.151430

Figure 1.

Figure 1

Global progress on programmatic use of bedaquiline (BDQ) to treat multidrug-resistant tuberculosis. Blue indicates countries using BDQ under program conditions. Green indicates countries awaiting arrival of BDQ to use it under program conditions. Gray indicates countries that have not reported using BDQ under program conditions.